Detalhe da pesquisa
1.
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Mol Ther;
30(9): 2984-2997, 2022 09 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35484842
2.
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
NPJ Vaccines;
9(1): 102, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38858404
3.
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Front Immunol;
14: 1208041, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37654495
4.
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
EMBO Mol Med;
15(10): e17723, 2023 Oct 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37675835
5.
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.
Cell Rep;
40(4): 111142, 2022 07 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35905717
6.
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Mucosal Immunol;
15(6): 1389-1404, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36104497
7.
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
EMBO Mol Med;
13(12): e14459, 2021 12 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34647691
8.
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Cell Host Microbe;
29(2): 236-249.e6, 2021 02 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33357418